Clinical Outcome and Therapeutic Impact on Neuroendocrine Neoplasms of the Breast: a National Cancer Database Study

Libo Yang,Heather Lin,Yu Shen,Madhuchhanda Roy,Constance Albarracin,Qingqing Ding,Lei Huo,Hui Chen,Bing Wei,Hong Bu,Isabelle Bedrosian,Yun Wu
DOI: https://doi.org/10.1007/s10549-023-07052-5
2023-01-01
Breast Cancer Research and Treatment
Abstract:Neuroendocrine neoplasms (NENs) of the breast are rare and not well-studied. NEN are subcategorized as well-differentiated neuroendocrine tumor (NET) and poorly differentiated neuroendocrine carcinoma (NEC). The objectives of the current study were to review the clinicopathologic features of NENs, therapeutic efficacy of current systemic therapy and clinical outcomes of NEN of the breast. Between 2004 and 2015, 420 NET, 205 NEC, 146 Adenocarcinoma with NE differentiation (ACNED) and 1,479,520 of invasive carcinoma, not otherwise specified (IC-NOS) of the breast were identified in the National Caner Database. Overall survival was compared among groups using Kaplan–Meier method and Log-rank test. Multivariate analyses were performed to identify prognostic factors. After adjusting for other prognostic factors, both NET and NEC of the breast showed significantly worse OS than IC-NOS (HR (95
What problem does this paper attempt to address?